tetraisopropylpyrophosphamide and Acute Edematous Pancreatitis

tetraisopropylpyrophosphamide has been researched along with Acute Edematous Pancreatitis in 2 studies

Tetraisopropylpyrophosphamide: N,N',N'',N'''-Tetraisopropylpyrophosphamide. A specific inhibitor of pseudocholinesterases. It is commonly used experimentally to determine whether pseudo- or acetylcholinesterases are involved in an enzymatic process.

Research Excerpts

Excerpt	Relevance	Reference
" Dose-response studies with acetylcholine were done on viable pancreas fragments from nine human donors, without pancreatic disease (group I)."	1.28	Organophosphate increases the sensitivity of human exocrine pancreas to acetylcholine. ( Borner, JW; Dressel, TD; Goodale, RL; Kandalaft, K; Liu, S; Manivel, C; Sutherland, DE, 1991)

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kandalaft, K	1
Liu, S	2
Manivel, C	1
Borner, JW	2
Dressel, TD	2
Sutherland, DE	1
Goodale, RL	2
Oguchi, Y	1
Runge, W	1

Other Studies

2 other studies available for tetraisopropylpyrophosphamide and Acute Edematous Pancreatitis

Article	Year
Organophosphate increases the sensitivity of human exocrine pancreas to acetylcholine. Pancreas, 1991, Volume: 6, Issue:4 Topics: Acetylcholine; Amylases; Cholinesterases; Dose-Response Relationship, Drug; Echothiophate Iodide; Hu	1991
Increased canine pancreatic acinar cell damage after organophosphate and acetylcholine or cholecystokinin. Pancreas, 1990, Volume: 5, Issue:2 Topics: Acetylcholine; Acute Disease; Animals; Cholecystokinin; Dogs; Drug Synergism; Echothiophate Iodide;	1990